#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pouchitis Chondrosarcoma B-cell small lymphocytic lymphoma refractory Herpes simplex Cholangiosarcoma Chronic myelomonocytic leukaemia B-cell small lymphocytic lymphoma B-cell lymphoma Granulomatosis with polyangiitis Autoimmune disorder Antiphospholipid antibodies ABO haemolytic disease of newborn Epidermolysis bullosa Squamous cell carcinoma of the vulva Mantle cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Osteosarcoma – Diagnostics Combined immunodeficiency – Treatment Atypical teratoid/rhabdoid tumour of CNS Glomerulonephritis membranoproliferative – Treatment Chondrosarcoma metastatic – Treatment MELAS syndrome – Treatment Haemophilia A with anti factor VIII – Treatment Basal cell naevus syndrome Sarcoidosis – Life with Disease Metachromatic leukodystrophy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gremubamab Sodium Chloride Letetresgene Autoleucel Everolimus Sotatercept Anselamimab Iron Sucrose Leuprorelin REGN7999 Trazodone Diphenhydramine Roginolisib Ropivacaine Dexketoprofen Nesolicaftor Iti-1284 Empasiprubart Ddcart‐Cd19 Tenofovir Alafenamide Boserolimab More therapies…

    Learn about Your Condition

    Hand dermatitis Vaginal infection Testicular germ cell tumour Intestinal obstruction Amyotrophic lateral sclerosis Lymphocytic leukaemia Cytomegalovirus infection Dementia Nasopharyngeal cancer Hairy cell leukaemia Schizophrenia Ischaemic stroke Rett syndrome Anal abscess Adrenocortical carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia

    Recruiting

    2 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Vafidemstat
    Bulgaria Poland Romania Slovakia Spain

  • Study on Betahistine Dihydrochloride for Treating Adults with Menière’s Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Betahistine Dihydrochloride
    Spain

  • Study on Amoxicillin for Patients with Chronic Low Back Pain and Modic Type I Changes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Amoxicillin
    The Netherlands

  • Study on Opioid Detoxification Using Buprenorphine, Naloxone, and Oxycodone for Patients with Persistent Spinal Pain Syndrome Type II

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Buprenorphine
    • Naloxone
    • Oxycodone Hydrochloride
    Belgium

  • A Study of Dabrafenib and Trametinib Treatment Before and After Surgery in Patients with Papillary Craniopharyngioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Craniopharyngioma
    Investigated Drugs:
    • Dabrafenib
    • Trametinib
    Sweden

  • Study on Treatments for Intermediate High-Risk Pulmonary Embolism: Comparing Percutaneous Embolectomy, Ultrasound-Assisted Thrombolysis with Alteplase, and Heparin

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Tinzaparin Sodium
    • Heparin
    • Alteplase
    Denmark
Previous Page
1 … 617 618 619 620 621 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!